1. Zamboni G, Pea M, Martignoni G, Zancanaro C, Faccioli G, Gilioli E, Pederzoli P, Bonetti F. Clear cell "sugar" tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol. 1996. 20:722–730.
2. Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, Ferrans VJ, Moss J. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis (LAM). Chest. 1999. 115:1041–1052.
3. Matsui K, Tatsuguchi A, Valencia J, Yu Z, Bechtle J, Beasley MB, Avila N, Travis WD, Moss J, Ferrans VJ. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol. 2000. 31:1242–1248.
Article
4. Chan JK, Tsang WY, Pau MY, Tang MC, Pang SW, Fletcher CD. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45 positive smooth muscle. Histopathology. 1993. 22:445–455.
5. National Heart, Lung, and Blood Institute. NHLBI Workshop Summary. Report of workshop on lymphangioleiomyomatosis. Am J Respir Crit Care Med. 1999. 159:679–683.
6. Jaiswal VR, Baird J, Fleming J, Miller DS, Sharma S, Molberg K. Localized retroperitoneal lymphangioleiomyomatosis mimicking malignancy. Arch Pathol Lab Med. 2003. 127:879–882.
Article
7. Kim GY, Lee J, Park YK, Kim YW, Park JH, Yang MH. Pulmonary lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia associated with tuberous sclerosis: A case report. Korean J Pathol. 2002. 36:51–54.
8. Mo EK, Jung MP, Yoo CG, Kim YW, Han SK, Im JG, Seo JW, Lee SS, Shim YS, Kim KY, Han YC. Lymphangioleiomyomatosis in Korea. Tuberc Respir Dis. 1993. 40:519–531.
Article
9. Kwon T, Chung NE. Pulmonary lymphangioleiomyomatosis associated with a fatal pneumothorax: an autopsy case report. Korean J Leg Med. 2000. 24:61–65.
10. Hancock E, Tomkins S, Sampson J, Osborne J. Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med. 2002. 96:7–13.
Article
11. Moss J, Avila NA, Barnes PM, Litzenberger RA, Bechtle J, Brooks PG, Hedin CJ, Hunsberger S, Kristof AS. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med. 2001. 164:669–671.
Article
12. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA. 2000. 97:6085–6090.
Article
13. Strizheva GD, Carsillo T, Kruger WD, Sullivan EJ, Ryu JH, Henske EP. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Resp Crit Care Med. 2001. 163:253–258.
14. Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, Moss J, Ferrans VJ. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med. 2000. 161:1002–1009.
15. Logginidou H, Ao X, Russo I, Henske EP. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest. 2000. 117:25–30.
Article
16. Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest. 1998. 114:1689–1703.